These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacogenomics--10 years of progress: a cardiovascular perspective. Winkelmann BR; Herrington D Pharmacogenomics; 2010 May; 11(5):613-6. PubMed ID: 20415546 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide studies in pharmacogenomics: harnessing the power of extreme phenotypes. Gurwitz D; McLeod HL Pharmacogenomics; 2013 Mar; 14(4):337-9. PubMed ID: 23438876 [No Abstract] [Full Text] [Related]
6. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine]. Mushiroda T Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182 [TBL] [Abstract][Full Text] [Related]
7. [Translational approach for pharmacogenomics and personalized medicine]. Zhang W; Zhou HH Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics and epilepsy: the road ahead. Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacogenomics: way to individual therapy]. Piruzian AL Eksp Klin Farmakol; 2005; 68(5):59-67. PubMed ID: 16277215 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of adverse drug reactions: implementing personalized medicine. Wei CY; Lee MT; Chen YT Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges. Gamazon ER; Perera M Pharmacogenomics; 2012 Jul; 13(10):1101-4. PubMed ID: 22909197 [No Abstract] [Full Text] [Related]
12. Pharmacogenomic approaches to study the effects of antihypertensive drugs. Kamide K; Kawano Y; Rakugi H Hypertens Res; 2012 Aug; 35(8):796-9. PubMed ID: 22739423 [TBL] [Abstract][Full Text] [Related]
13. Beyond the clinic: 'direct-to-consumer' genomic profiling services and pharmacogenomics. Prainsack B; Vayena E Pharmacogenomics; 2013 Mar; 14(4):403-12. PubMed ID: 23438887 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic biomarkers for personalized medicine. Chen JJ; Lin WJ; Chen HC Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190 [TBL] [Abstract][Full Text] [Related]
15. ["Book of life" : On course for personalized anesthesia?]. Adamzik M Anaesthesist; 2013 Nov; 62(11):872-3. PubMed ID: 24158654 [No Abstract] [Full Text] [Related]
16. Genome-wide association studies. Al-Chalabi A Cold Spring Harb Protoc; 2009 Dec; 2009(12):pdb.top66. PubMed ID: 20150103 [No Abstract] [Full Text] [Related]
17. Role of genomics on the path to personalized medicine. Tremblay J; Hamet P Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037 [TBL] [Abstract][Full Text] [Related]
18. Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence? Kalf RR; Bakker R; Janssens AC Pharmacogenomics; 2013 Mar; 14(4):341-4. PubMed ID: 23438877 [No Abstract] [Full Text] [Related]
19. Pharmacogenetics using Luminex® xMAP® technology: a method for developing a custom multiplex single nucleotide polymorphism mutation assay. Spierings G; Dunbar SA Methods Mol Biol; 2013; 1015():115-26. PubMed ID: 23824852 [TBL] [Abstract][Full Text] [Related]
20. Personalized medicine - the promised land: are we there yet? Li C Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]